Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature.
PubWeight™: 0.75‹?›
Published in Nanoscale on August 11, 2017
Author Affiliations
1: Translational Prostate Cancer Research Group, University of Alberta, 5-142C Katz Group Building, 114th St and 87th Ave, Edmonton, AB T6G 2E1, Canada. jdlewis@ualberta.ca and Harvey Cushing Neuro-Oncology Laboratories, Brigham and Women's Hospital, Harvard Medical School, Building of Transformative Medicine, 60 Fenwood Road, Boston, MA 02115, USA.
2: London Regional Cancer Program, 800 Commissioners Rd. E., London, ON, N6A 4L6 Canada.
3: Translational Prostate Cancer Research Group, University of Alberta, 5-142C Katz Group Building, 114th St and 87th Ave, Edmonton, AB T6G 2E1, Canada. jdlewis@ualberta.ca.
4: Department of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA.
5: Department of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA and Department of Radiology, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA and Department of Materials Science and Engineering, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA and Department of Macromolecular Science and Engineering, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA.
6: Department of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA and Departments of Chemistry, Oncology, Medical Imaging, The University of Western Ontario, London, ON, N6A 5C1 Canada.
7: Department of Oncology, University of Alberta, Edmonton, Alberta, Canada T6G 2E1.
Articles by these authors ⇆